User profiles for "author:Balázs Győrffy"
Balázs GyőrffyClarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of … Verified email at ttk.mta.hu Cited by 27954 |
[HTML][HTML] Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Multiple studies suggested using different miRNAs as biomarkers for prognosis of
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …
[HTML][HTML] Multigene prognostic tests in breast cancer: past, present, future
There is growing consensus that multigene prognostic tests provide useful complementary
information to tumor size and grade in estrogen receptor (ER)-positive breast cancers. The …
information to tumor size and grade in estrogen receptor (ER)-positive breast cancers. The …
[HTML][HTML] Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
O Menyhárt, B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
While cost-effective high-throughput technologies provide an increasing amount of data, the
analyses of single layers of data seldom provide causal relations. Multi-omics data …
analyses of single layers of data seldom provide causal relations. Multi-omics data …
[HTML][HTML] Web-based survival analysis tool tailored for medical research (KMplot): development and implementation
A Lánczky, B Győrffy - Journal of medical Internet research, 2021 - jmir.org
Background Survival analysis is a cornerstone of medical research, enabling the
assessment of clinical outcomes for disease progression and treatment efficiency. Despite …
assessment of clinical outcomes for disease progression and treatment efficiency. Despite …
[HTML][HTML] Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer
B Győrffy, P Surowiak, J Budczies, A Lánczky - PloS one, 2013 - journals.plos.org
In the last decade, optimized treatment for non-small cell lung cancer had lead to improved
prognosis, but the overall survival is still very short. To further understand the molecular …
prognosis, but the overall survival is still very short. To further understand the molecular …
[HTML][HTML] Pancancer survival analysis of cancer hallmark genes
Á Nagy, G Munkácsy, B Győrffy - Scientific reports, 2021 - nature.com
Cancer hallmark genes are responsible for the most essential phenotypic characteristics of
malignant transformation and progression. In this study, our aim was to estimate the …
malignant transformation and progression. In this study, our aim was to estimate the …
[HTML][HTML] Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
Introduction Extensive research is directed to uncover new biomarkers capable to stratify
breast cancer patients into clinically relevant cohorts. However, the overall performance …
breast cancer patients into clinically relevant cohorts. However, the overall performance …
[HTML][HTML] Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
Gene or protein expression data are usually represented by metric or at least ordinal
variables. In order to translate a continuous variable into a clinical decision, it is necessary to …
variables. In order to translate a continuous variable into a clinical decision, it is necessary to …
[HTML][HTML] Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
Results The entire database incorporates 1,065 gastric carcinoma samples, gene
expression data. Out of 29 established markers, higher expression of BECN1 (HR= 0.68, p …
expression data. Out of 29 established markers, higher expression of BECN1 (HR= 0.68, p …
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
B Győrffy, A Lánczky, Z Szállási - Endocrine-related cancer, 2012 - real.mtak.hu
The validation of prognostic biomarkers in large independent patient cohorts is a major
bottleneck in ovarian cancer research. We implemented an online tool to assess the …
bottleneck in ovarian cancer research. We implemented an online tool to assess the …